Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease sclerosing cholangitis
Phenotype C0206698|cholangiocarcinoma
Sentences 16
PubMedID- 25636976 Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
PubMedID- 20508074 A case of intrahepatic cholangiocarcinoma associated with primary sclerosing cholangitis.
PubMedID- 23007734 Background: carbohydrate antigen 19-9 (ca 19-9) is the serum marker used to diagnose cholangiocarcinoma (cca) in patients with primary sclerosing cholangitis (psc).
PubMedID- 25690752 Liver transplantation and whipple surgery combined with chemoradiotherapy for treatment of hilar cholangiocarcinoma in patients with primary sclerosing cholangitis.
PubMedID- 25500329 Volatile organic compounds in bile for early diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis: a pilot study.
PubMedID- 23958938 Fut2 and fut3 genotype determines ca19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis.
PubMedID- 21603286 Ca19-9 was useful for predicting cholangiocarcinoma in patients with primary sclerosing cholangitis, with the sensitivity being 79%, the specificity 99%, the adjusted positive predictive value 57% and the negative predictive value 99% (49).
PubMedID- 20216413 An update on cholangiocarcinoma associated with primary sclerosing cholangitis.
PubMedID- 22722442 In the literature, cholangiocarcinoma in patients with igg4- related sclerosing cholangitis was not described, whereas cholangiocarcinoma develops in up to 10-30% of patients with psc.
PubMedID- 24577150 Trends in pre-liver transplant screening for cholangiocarcinoma among patients with primary sclerosing cholangitis.
PubMedID- 21884553 De novo cholangiocarcinoma associated with recurrent primary sclerosing cholangitis in the transplanted liver is rare.
PubMedID- 21374660 Early detection of malignant biliary tract diseases, especially cholangiocarcinoma (cc) in patients with primary sclerosing cholangitis (psc), is very difficult and often comes too late to give the patient a therapeutic benefit.
PubMedID- 23894567 Various cohort studies showed an increased occurrence of cholangiocarcinoma in patients with primary sclerosing cholangitis, ranging from 10% to 13% [6]–[8].
PubMedID- 25132998 Moreover, igg4-related disease is a high-risk factor for cancer development; igg4-related sclerosing cholangitis (igg4-sc) cases associated with cholangiocarcinoma or its precursor lesion biliary intraepithelial neoplasia (bilin) have been reported.
PubMedID- 25259419 Early diagnosis of dysplastic changes and exclusion of cholangiocarcinoma (cca) in patients with primary sclerosing cholangitis (psc) remain a major clinical challenge.
PubMedID- 25623660 Objectives: polysomy detected by fluorescence in situ hybridization (fish) is associated with cholangiocarcinoma (cca) in patients with primary sclerosing cholangitis (psc).

Page: 1